Division of Nephrology, Department of Pediatrics, University of New Mexico Health Systems, Albuquerque, NM.
Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Am J Kidney Dis. 2019 Jun;73(6):837-845. doi: 10.1053/j.ajkd.2019.01.020. Epub 2019 Mar 14.
DNA is now commonly collected in clinical research either for immediate genomic analyses or stored for future studies. Many genomic studies were previously designed without awareness of the ethical issues that might arise regarding the disclosure of genomic test results. At the start of the Chronic Kidney Disease in Children (CKiD) Cohort Study in 2004, we did not foresee the advent of genomic technology or the associated ethical issues pertaining to genetic research in children. Recent genomic studies and ancillary proposals using genomic technology stimulated the CKiD investigators to reassess the current ethical and policy environment pertaining to genomic testing and results disclosure. We consider the issues pertaining to next generation sequencing and individual results disclosure that may guide current and future research practices.
现在,在临床研究中通常会收集 DNA,以便进行即时的基因组分析,或者将其储存起来用于未来的研究。许多基因组研究在设计时并未意识到可能会出现与基因组检测结果披露相关的伦理问题。在 2004 年开始的儿童慢性肾脏病(CKiD)队列研究中,我们没有预见到基因组技术的出现,也没有预见到与儿童遗传研究相关的伦理问题。最近的基因组研究和使用基因组技术的辅助提案促使 CKiD 研究人员重新评估当前与基因组检测和结果披露相关的伦理和政策环境。我们考虑了与下一代测序和个体结果披露相关的问题,这些问题可能为当前和未来的研究实践提供指导。